Tubulointerstitial fibrosis
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Glomerulosclerosis and tubulointerstitial fibrosis are hallmarks of chronic kidney injury leading to end-stage renal disease.
|
30597038 |
2020 |
NAVAJO NEUROHEPATOPATHY
|
0.760 |
GeneticVariation
|
disease |
UNIPROT |
The zebrafish orthologue of the human hepatocerebral disease gene MPV17 plays pleiotropic roles in mitochondria.
|
30833296 |
2019 |
NAVAJO NEUROHEPATOPATHY
|
0.760 |
GeneticVariation
|
disease |
BEFREE |
MPV17 mutations were first reported in patients with Navajo neurohepatopathy, an autosomal recessive mitochondrial DNA depletion syndrome, characterized by early-onset liver failure, failure to thrive as well as central and peripheral neurological involvement.
|
30298599 |
2019 |
Liver Failure
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
Moreover, a novel splice site mutation in MPV17 gene (c.461 + 1G > C) was identified in a patient with jaundice, muscle weakness, and failure to thrive who died due to hepatic failure at the age of 4 months.
|
31664948 |
2019 |
Failure to Thrive
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
Moreover, a novel splice site mutation in MPV17 gene (c.461 + 1G > C) was identified in a patient with jaundice, muscle weakness, and failure to thrive who died due to hepatic failure at the age of 4 months.
|
31664948 |
2019 |
SYMPHALANGISM, PROXIMAL
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Proximal symphalangism (SYM1; OMIM 185800), also called Cushing's symphalangism, is an infrequent autosomal dominant disease.
|
31370824 |
2019 |
Mixed sensory-motor polyneuropathy
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
MPV17 mutations in juvenile- and adult-onset axonal sensorimotor polyneuropathy.
|
30298599 |
2019 |
Pediatric failure to thrive
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Moreover, a novel splice site mutation in MPV17 gene (c.461 + 1G > C) was identified in a patient with jaundice, muscle weakness, and failure to thrive who died due to hepatic failure at the age of 4 months.
|
31664948 |
2019 |
Failure to thrive in infant
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Moreover, a novel splice site mutation in MPV17 gene (c.461 + 1G > C) was identified in a patient with jaundice, muscle weakness, and failure to thrive who died due to hepatic failure at the age of 4 months.
|
31664948 |
2019 |
Arteriosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Glomerulosclerosis associated more strongly with arteriosclerosis and ischemic-appearing glomeruli in the superficial region.
|
31278193 |
2019 |
IGA Glomerulonephritis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Crescents and Global Glomerulosclerosis in Chinese IgA Nephropathy Patients: A Five-Year Follow-Up.
|
30808856 |
2019 |
Icterus
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Moreover, a novel splice site mutation in MPV17 gene (c.461 + 1G > C) was identified in a patient with jaundice, muscle weakness, and failure to thrive who died due to hepatic failure at the age of 4 months.
|
31664948 |
2019 |
Axonal neuropathy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
This report provides further evidence that MPV17 mutations should be considered in patients with pure, non-syndromic axonal neuropathy.
|
30298599 |
2019 |
NAVAJO NEUROHEPATOPATHY
|
0.760 |
CausalMutation
|
disease |
CLINVAR |
In 2006, pathogenic variants in MPV17 were first reported to cause infantile-onset hepatocerebral mtDNA depletion syndrome and Navajo neurohepatopathy.
|
29282788 |
2018 |
NAVAJO NEUROHEPATOPATHY
|
0.760 |
GeneticVariation
|
disease |
CLINVAR |
In 2006, pathogenic variants in MPV17 were first reported to cause infantile-onset hepatocerebral mtDNA depletion syndrome and Navajo neurohepatopathy.
|
29282788 |
2018 |
NAVAJO NEUROHEPATOPATHY
|
0.760 |
GeneticVariation
|
disease |
UNIPROT |
In 2006, pathogenic variants in MPV17 were first reported to cause infantile-onset hepatocerebral mtDNA depletion syndrome and Navajo neurohepatopathy.
|
29282788 |
2018 |
NAVAJO NEUROHEPATOPATHY
|
0.760 |
GeneticVariation
|
disease |
BEFREE |
In 2006, pathogenic variants in MPV17 were first reported to cause infantile-onset hepatocerebral mtDNA depletion syndrome and Navajo neurohepatopathy.
|
29282788 |
2018 |
Peripheral Nervous System Diseases
|
0.020 |
Biomarker
|
group |
BEFREE |
Rarely, MPV17 deficiency can cause a late-onset neuromyopathic disease characterized by myopathy and peripheral neuropathy with no or minimal liver involvement.
|
29282788 |
2018 |
Myoclonic Epilepsy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The phenotypes & genotypes included Mitochondrial Encephalopathy Lactic Acidosis and Stroke like episodes (MELAS) & m.3243A>G mutation (n = 10), Myoclonic Epilepsy Ragged Red Fiber syndrome (MERRF) & m.8344A>G mutation (n = 4), Chronic Progressive External Ophthalmoplegia plus &POLG1 mutation (CPEO, n = 6), episodic neuroregression due to nuclear mutations (n = 6; NDUFV1 (n = 3), NDUFA1, NDUFS2, MPV17-1 one each), and one patient with infantile basal ganglia stroke syndrome, mineralizing angiopathy &MT-ND5 mutations.
|
29272804 |
2018 |
Myopathy
|
0.010 |
Biomarker
|
group |
BEFREE |
Rarely, MPV17 deficiency can cause a late-onset neuromyopathic disease characterized by myopathy and peripheral neuropathy with no or minimal liver involvement.
|
29282788 |
2018 |
Peripheral Neuropathy
|
0.010 |
Biomarker
|
group |
BEFREE |
Rarely, MPV17 deficiency can cause a late-onset neuromyopathic disease characterized by myopathy and peripheral neuropathy with no or minimal liver involvement.
|
29282788 |
2018 |
Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-like episodes (MELAS syndrome)
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The phenotypes & genotypes included Mitochondrial Encephalopathy Lactic Acidosis and Stroke like episodes (MELAS) & m.3243A>G mutation (n = 10), Myoclonic Epilepsy Ragged Red Fiber syndrome (MERRF) & m.8344A>G mutation (n = 4), Chronic Progressive External Ophthalmoplegia plus &POLG1 mutation (CPEO, n = 6), episodic neuroregression due to nuclear mutations (n = 6; NDUFV1 (n = 3), NDUFA1, NDUFS2, MPV17-1 one each), and one patient with infantile basal ganglia stroke syndrome, mineralizing angiopathy &MT-ND5 mutations.
|
29272804 |
2018 |
NAVAJO NEUROHEPATOPATHY
|
0.760 |
GeneticVariation
|
disease |
UNIPROT |
Nucleotide pools dictate the identity and frequency of ribonucleotide incorporation in mitochondrial DNA.
|
28207748 |
2017 |
Liver Failure
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
Mutations in human MPV17 have been reported in patients with severe mitochondrial DNA (mtDNA) depletion manifesting as early childhood onset failure to thrive, hypoglycemia, encephalopathy and progressive liver failure.
|
28673863 |
2017 |
Deoxyguanosine Kinase Deficiency
|
0.230 |
Biomarker
|
disease |
BEFREE |
MPV17 hepatocerebral mitochondrial DNA depletion syndrome presenting as acute flaccid paralysis - A case report.
|
28673863 |
2017 |